FDA Drug Application (062483) for GRIFULVIN V by VALEANT LUXEMBOURG

Back to FDA Applications sponsored by VALEANT LUXEMBOURG

Application Number062483
Product Number001
FormSUSPENSION;ORAL
Dosage125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameGRIFULVIN V
Active IngredientGRISEOFULVIN, MICROSIZE



Back to FDA Applications sponsored by VALEANT LUXEMBOURG

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.